The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Tuesday recommended Bharat Biotech's intranasal vaccine for conducting phase 1 clinical trials for the coronavirus

Coronavirus vaccination drive: Dr Paul said that there are currently 5,000 vaccination points in the country. The number will be doubled up in a matter of weeks. Allow us to develop the system in an effective way and then scale it up dramatically, he said

Initial 30 crore vaccinations (60 crore doses) planned by the Centre would have cost Rs 13,200 crore. However, need for 66 crore doses raises the cost by Rs 1320 crore

(For) all our vaccines, we are looking at right now..(we) are targeting 2-8 degree because our logistics are worked out on that basis and we are working on that, DBT secretary Renu Swarup said at a press briefing

Defending Covaxin, the Bhart Biotech Chairman said that his company has tremendous experience in developing vaccines; more than 70 articles on data related to Covaxin have been published in various journals

Coronavirus vaccine in India: Adar Poonawalla, CEO of Serum Institute of India that is manufacturing Covishield had said that the company is ready to roll out its vaccine in the coming weeks

Coronavirus vaccine dry run in Delhi: Union Health Minister Harsh Vardhan visited Delhi's Guru Teg Bahadur hospital to review dry run of coronavirus vaccine today

Coronavirus vaccination drive: The task force has added 31 COVID-19 vaccine hubs that will supply vaccines to 29,000 vaccination points

The ministry underlined that all public health facilities in the country had only around 16,000 ventilators from the Independence till pre-COVID times

CBSE 2021 exam date announcement today: Students will be able to access the detailed date sheet of class 10 and 12 board exam on the official CBSE website

Johnson has urged MPs to back the \" historic\" bill, which he says is not \"a rupture but a resolution\" of the UK's relationship with its European neighbours

Indian Banking Sector 2019-20: The credit off-take from the industry declined marginally while agri, services and retail were in positive territory in 2019-20

The European Medicines Agency's  Deputy Executive Director Noel Wathion has said AstraZeneca and the University of Oxford have not filed an application for approval until now

The validity extension applies to all documents, which were supposed to expire on February 1, 2020, and to those which would expire by March 31, 2021

India and Australia can combine complementary skills and expertise to develop new innovations by leveraging Australian expertise with Indian expertise including in data analytics, biotech, and mobile applications

Sanjiv Mehta delegated responsibility and relied on quick market feedback and cost control in order to thrive in the marketplace

If needed, the company could provide a new vaccine technically within six weeks to deal with the new mutated strain detected in Britain, says BioNTech CEO Ugur Sahin

Tech spend is expected to increase to $2.9 trillion by 2021. We are looking at a seismic shift in the scaling of digitization at a pace never seen before, said Rakesh Rathi

As many as 341 new fatalities were reported in the past 24 hours, pushing the overall death toll to 1,45,477.  India's COVID-19 case fatality rate is 1.45 per cent, which is one of the lowest in the world

Despite the rise in cases, India's Covid-19 recoveries have witnessed a steep exponential rise -- from 50,000 in May to over 95 lakh in December. Recoveries are more than 30 times active cases, says  HealthMin